BiotechTube
Home/PaxMedica/David H. Koschitzki
DH

David H. Koschitzki

Chief Operating Officer

PaxMedica

Therapeutic Areas

NeurologyNeurodevelopmental Disorders

PaxMedica Pipeline

DrugIndicationPhase
PAX-101 (IV Suramin)Autism Spectrum Disorder (ASD)Phase 3

Leadership Team at PaxMedica

HW
Howard Weisman
Chief Executive Officer and Chairman
SS
Stephen Sheldon
Chief Financial Officer
View full PaxMedica profile